Last mentioned: Mar 16, 2026
Implementation Phase
State health agencies begin establishing distribution protocols under the new law.
Law Signed
Governor signs the law, enabling the Department of Corrections to begin distribution to providers.
Legislation Passed
New law is enacted to simplify the distribution process from the state to clinics.
Bill Signed into Law
Governor Inslee signs the measure, enabling the Department of Corrections to begin distribution to providers.
Legislation Passed
Washington legislature passes bill to clarify state distribution authority.
Legislation Introduced
State lawmakers introduce a bill to clarify the state's authority to distribute the stockpile to clinics.
SCOTUS Ruling
Supreme Court preserves access to mifepristone on standing grounds, but litigation continues.
Inventory Secured
The Washington Department of Corrections receives and stores the medication supply.
Procurement Completed
The Department of Corrections receives the full shipment of the medication.
Stockpile Authorized
Gov. Jay Inslee directs the purchase of 30,000 doses of mifepristone.
Stockpile Ordered
Governor Inslee directs the purchase of 30,000 doses of mifepristone following a Texas court ruling.
Initial Stockpile Purchase
Governor Inslee orders 30,000 doses of mifepristone following a Texas court ruling.
Washington Governor has signed legislation authorizing the state to distribute its 30,000-dose stockpile of mifepristone to private and non-profit healthcare providers. The law resolves previous licensing hurdles that prevented the state's Department of Corrections from acting as a wholesale distributor for reproductive health medications.
Washington Governor Jay Inslee has signed legislation allowing the state to efficiently distribute its 30,000-dose stockpile of mifepristone to healthcare providers. The move solidifies the state's role as a direct supplier of reproductive healthcare in response to ongoing federal legal uncertainty.
Washington state has enacted legislation to facilitate the distribution of its mifepristone stockpile to healthcare providers, ensuring continued access amidst ongoing federal legal uncertainty. The law removes administrative barriers that previously complicated the transfer of state-purchased medication to private and public clinics.